Keros Therapeutics (KROS) Operating Income Growth (1y) (2020 - 2025)
Keros Therapeutics (KROS) Operating Income Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 1,386.07% |
| 10 | Keros Therapeutics | 384.68 Mn | 97.28 Mn | - | 45.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45.04% |
| Sep 30, 2025 | 73.77% |
| Jun 30, 2025 | 21.06% |
| Mar 31, 2025 | 413.59% |
| Dec 31, 2024 | -14.64% |
| Sep 30, 2024 | -35.53% |
| Jun 30, 2024 | -22.02% |
| Mar 31, 2024 | -24.73% |
| Dec 31, 2023 | -45.35% |
| Sep 30, 2023 | -54.70% |
| Jun 30, 2023 | -34.53% |
| Mar 31, 2023 | -61.11% |
| Dec 31, 2022 | -556.80% |
| Sep 30, 2022 | -38.52% |
| Jun 30, 2022 | -97.72% |
| Mar 31, 2022 | -53.00% |
| Dec 31, 2021 | 63.39% |
| Sep 30, 2021 | -69.04% |
| Jun 30, 2021 | -42.40% |
| Mar 31, 2021 | -50.12% |